Summary by Moomoo AI
Vertex Pharmaceuticals Inc. officer, Tatsis Ourania, is set to sell 2,175 shares of common stock on 06/03/2024, with an aggregate market value of approximately $1,000,500. The shares to be sold were acquired through restricted stock vesting as part of compensation on two separate occasions, with 740 shares acquired on 02/17/2024 and an additional 1,435 shares on 02/20/2024, both from the issuer. This planned sale follows a recent transaction history where a total of 4,600 shares were sold over the past three months, generating gross proceeds of $2,033,158.5.